Polymorphisms of Interleukin 4 Receptor Gene and Interleukin 10 Gene are not Associated with Graves' Disease in the UK

References

• Payami, H., Joe, S. and Thomson, G. (1989) "Autoimmune thyroid disease in type I diabetic families", Genet. Epidemiol. 6(1), 137–141.
   Google Scholar
• Allen, C., Palta, M. and D'Alessio, D.J. (1991) "Risk of diabetes in siblings and other relatives of IDDM subjects", Diabetes 40(7), 831–836.
   PubMedGoogle Scholar
• Becker, KG. (1999) "Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?", Diabetes 48(7), 1353–1358.
   PubMedGoogle Scholar
• Moore, K.W., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T.R. (1993) "Interleukin-10", Annu. Rev. Immunol. 11, 165–190.
   PubMedGoogle Scholar
• Deichmann, K., Bardutzky, J., Forster, J., Heinzmann, A. and Kuehr, J. (1997) "Common polymorphisms in the coding part of the 1L4-receptor gene", Biochem. Biophys. Res. Commun. 231(3), 696–697.
   Google Scholar
• Mitsuyasu, H., Izuhara, K., Mao, X.Q., Gao, P.S., Arinobu, Y, Enomoto, T., et al. (1998) "Ile50Val variant of 1L4R alpha upregulates IgE synthesis and associates with atopic asthma", Nat. Genet. 19(2), 119–120.
   PubMedGoogle Scholar
• Kanemitsu, S., Takabayashi, A., Sasaki, Y, Kuromaru, R., Ihara, K., Kaku, Y, et al. (1999) "Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus", Arthritis Rheum. 42(6), 1298–1300.
   PubMedGoogle Scholar
• Beebe, A.M., Cua, D.J. and de Waal Malefyt, R. (2002) "The role of interleukin-10 in autoimmune disease: systemic lupus erythemato-sus (SLE) and multiple sclerosis (MS)", Cytokine Growth Factor Rev. 13(4–5), 403–412.
   Google Scholar
• Gibson, A.W., Edberg, J.C., Wu, J., Westendorp, R.G., Huizinga, T.W. and Kimberly, R.P. (2001) "Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus", J. Immunol. 166(6), 3915–3922.
   PubMed Web of Science ®Google Scholar
• Eskdale, J., McNicholl, J., Wordsworth, P., Jonas, B., Huizinga, T., Field, M., et al. (1998) "Interleukin-10 microsatellite polymorph-isms and IL-10 locus alleles in rheumatoid arthritis susceptibility", Lancet 352(9136), 1282–1283.
   PubMed Web of Science ®Google Scholar
• Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L.J. and Borish, L. (1998) "Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma", Am. J. Respir. Grit. Care Med. 158(6), 1958–1962.
   Google Scholar
• Lim, S., Crawley, E., Woo, P. and Barnes, P.J. (1998) "Haplotype associated with low interleukin-10 production in patients with severe asthma", Lancet 352(9122), 113.
   PubMedGoogle Scholar
• Hajeer, A.H., Lazarus, M., Turner, D., Mageed, R.A., Vencovsky, J., Sinnott, P., et al. (1998) "IL-10 gene promoter polymorphisms in rheumatoid arthritis", Scand. J. Rheumatol. 27(2), 142–145.
   Google Scholar
• Lazarus, M., Hajeer, A.H., Turner, D., Sinnott, P., Worthington, J., Oilier, WE., et al. (1997) "Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus", J. Rheumatol. 24(12), 2314–2317.
   PubMed Web of Science ®Google Scholar
• Johnson, G.C., Esposito, L., Barratt, B.J., Smith, AN., Heward, J., Di Genova, G., et al. (2001) "Haplotype tagging for the identification of common disease genes", Nat. Genet. 29(2), 233–237.
   PubMedGoogle Scholar
• Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., et al. (2003) "Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease", Nature.
   Google Scholar
• Lu, P., Zhou, X.D., Chen, S.J., Moorman, M., Schoneveld, A., Morris, S., et al. (1995) "Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response", J. Immunol. 154(3), 1078–1087.
   PubMedGoogle Scholar
• Heward, J.M., Nithiyananthan, R., Allahabadia, A., Gibson, S., Franklyn, J.A. and Gough, S.C. (2001) "No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom", J. Clin. Endocrinol. Metab. 86(8), 3861 —3863.
   Google Scholar
• Heward, J.M., Allahabadia, A., Daykin, J., Carr-Smith, J., Daly, A., Armitage, M., et al. (1998) "Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompat-ibility complex and Graves' disease: replication using a population case control and family-based study", J. Clin. Endocrinol. Metab. 83(10), 3394–3397.
   PubMedGoogle Scholar
• Heward, J.M., Allahabadia, A., Armitage, M., Hattersley, A., Dodson, P.M., Macleod, K., et al. (1999) "The development of Graves' disease and the CTLA-4 gene on chromosome 2q33", J. Clin. Endocrinol. Metab. 84(7), 2398–2401.
   Google Scholar
• Allahabadia, A., Heward, J.M., Nithiyananthan, R., Gibson, S.M., Reuser, T.T., Dodson, P.M., et al. (2001) "MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease", Lancet 358(9286), 984–985.
   PubMedGoogle Scholar
• Csaszar, A. and Abel, T. (2001) "Receptor polymorphisms and diseases", Eur. J. Phannacol. 414(1), 9–22.
   PubMedGoogle Scholar
• Hackstein, H., Hecker, M., Kruse, S., Bohnert, A., Ober, C., Deichmann, K.A., et al. (2001) "A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels", Immunogenetics 53(4), 264–269.
   PubMedGoogle Scholar
• D'Alfonso, S., Rampi, M., Rolando, V., Giordano, M. and Momigliano-Richiardi, P. (2000) "New polymorphisms in the IL-10 promoter region", Genes Immun. 1(3), 231–233.
   PubMedGoogle Scholar
• Kruse, S., Japha, T., Tedner, M., Sparholt, S.H., Forster, J., Kuehr, J., et al. (1999) "The polymorphisms 5503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction", Immunology 96(3), 365–371.
   PubMedGoogle Scholar
• Yanagawa, T., Hidaka, Y, Guimaraes, V., Soliman, M. and DeGroot, L.J. (1995) "CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population", J. Clin. Endocrinol. Metab. 80(1), 41–45.
   Google Scholar
• Tomer, Y., Barbesino, G., Keddache, M., Greenberg, D.A. and Davies, T.F. (1997) "Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31", J. Qin. Endo-crinol. Metab. 82(5), 1645–1648.
   Google Scholar
• Tomer, Y, Barbesino, G., Greenberg, D.A., Concepcion, E. and Davies, T.F. (1999) "Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions", J. Clin. Endocrinol. Metab. 84(12), 4656–4664.
   Google Scholar
• Lander, ES. (1996) "The new genomics: global views of biology", Science 274(5287), 536–539.
   PubMed Web of Science ®Google Scholar
• Tabor, H.K., Risch, N.J. and Myers, R.M. (2002) "Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations", Nat. Rev. Genet. 3(5), 391–397.
   Google Scholar